4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-22-016049
Options or other derivatives
- SVP, Chief Legal Officer acquired 271,740 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Daly Jason B. SVP, Chief Legal Officer | 2022-03-03 | Grant or award · Restricted Stock Units | +90,580 | 90,580 | D | ||
| Daly Jason B. SVP, Chief Legal Officer | 2022-03-03 | Grant or award · Performance-Based Restricted Stock Units | +181,160 | 181,160 | D | ||
Loading xslF345X03/doc4.xml…